Business Context and Reporting Period
Company: Exponent, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: April 2, 2010
Business Overview: Exponent is an engineering and scientific consulting firm providing solutions to complex problems across more than 90 technical disciplines. Services include product development analysis, regulatory compliance, litigation support, and environmental/health sciences consulting.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Total Revenues | $59,406,000 | $59,796,000 |
| Revenues Before Reimbursements | $55,201,000 | $54,931,000 |
| Operating Income | $9,507,000 | $9,176,000 |
| Net Income | $6,239,000 | $5,758,000 |
| Diluted EPS | $0.42 | $0.38 |
| Cash and Cash Equivalents | $68,367,000 | $22,400,000 (End of Q1 2009) |
| Short-term Investments | $4,245,000 | $7,490,000 (Jan 1, 2010) |
| Operating Cash Flow | $1,437,000 | ($6,406,000) |
| EBITDA | $11,540,000 | $10,412,000 |
Material Changes vs. Prior Period
- Revenue: Total revenues decreased 0.7% year-over-year. Revenues before reimbursements increased 0.5%. The decline was driven by a 2.6% decrease in billable hours and a 43% drop in product sales (surveillance systems to the U.S. Army), partially offset by higher billing rates.
- Profitability: Net income increased 8% and diluted EPS rose to $0.42. Operating income improved by 3.6% due to effective headcount management, which increased utilization from 70% to 71% despite a 3.3% reduction in technical full-time equivalents.
- Expenses: Compensation expenses remained flat (-0.2%). Other operating expenses decreased 1.1% due to cost management. General and administrative expenses increased 2.4% primarily due to higher legal fees.
- Cash Flow: Operating cash flow turned positive ($1.4M) compared to a negative $6.4M in the prior year, driven by improved collections (Days Sales Outstanding decreased from 99 to 96 days) and better management of accounts payable.
- Segment Performance: The "Engineering and other scientific" segment saw a 1.2% revenue decline, while the "Environmental and health" segment grew 0.9%.
Guidance, Outlook, and Risks
- Outlook: Management expects average technical full-time equivalents to be flat in Q2 2010 with slight growth in the second half. They anticipate slight increases in compensation expenses due to annual salary adjustments. The company plans to continue managing costs, generating cash, and repurchasing shares.
- Stock Repurchases: The company repurchased 139,941 shares for $3.8 million during the quarter. Approximately $18.1 million remains authorized under current repurchase plans.
- Contingencies:
- Former Client Claim: A writ was served in 2008 regarding testimony that allegedly contributed to an adverse verdict. The verdict is under appeal; the company believes it has a strong defense and potential insurance coverage.
- Negligence Lawsuit: A third-party claim alleging negligence in evidence disposal is set for trial in May 2010. Damages are alleged to be less than $3 million. The company expects no material adverse effect.
- Risks: Key risks include the lack of a sizable backlog (revenues are event-driven), dependence on key employees, economic downturns affecting discretionary spending, and potential tort reform reducing demand for litigation support.
Investor Verification Checklist
- Utilization Rates: Verify the sustainability of the 71% utilization rate given the reduction in headcount.
- Product Sales Volatility: Assess the impact of the 43% decline in product sales to the U.S. Army on future revenue stability.
- Deferred Compensation Plan: Review the $569,000 increase in compensation expense (and corresponding other income) driven by market value changes in the deferred compensation plan assets.
- Legal Exposure: Monitor the outcome of the May 2010 trial regarding the evidence disposal negligence claim.
- Cash Conversion: Confirm the trend of improving Days Sales Outstanding (96 days) continues in subsequent quarters.